Logo image
Back
First Successful LVAD Implantation After BioVentrix Revivent TC Ventricular Reshaping
Journal article   Peer reviewed

First Successful LVAD Implantation After BioVentrix Revivent TC Ventricular Reshaping

Arianne Clare Agdamag, Andrew Shaffer, Ranjit John, Andrew S. Wechsler, Marc Pritzker, Meg Fraser, Cindy M. Martin, Rebecca Cogswell and Tamas Alexy
The Annals of thoracic surgery, v 112(2), pp e123-e126
Aug 2021
DOI: https://doi.org/10.1016/j.athoracsur.2020.11.052
PMID: 33444578
Featured in Collection :   UN Sustainable Development Goals @ Drexel

Abstract

The Revivent TC System (BioVentrix Inc, San Ramon, CA) enables a less invasive approach for left ventricular reshaping and scar exclusion in selected patients with ischemic cardiomyopathy. Although the system is designed to improve quality of life and to promote reverse remodeling, patients can still progress to end-stage heart failure requiring advanced therapies. This report describes a case of left ventricular assist device surgery in a patient 16 months after Revivent System implantation. The planning process and surgical technique proved to be complex. This case report can help provide guidance to advanced heart failure teams who encounter patients with the Revivent System who require left ventricular assist device support.

Metrics

15 Record Views
3 citations in Web of Science
4 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Cardiac & Cardiovascular Systems
Respiratory System
Surgery
Logo image